LeMaitre Vascular (LMAT) Total Debt to Capital

LeMaitre Vascular, Inc. (LMAT) relies on its own high-tech manufacturing plants in Europe and the US to produce sterile vascular implants. This chart illustrating the historical change in the total debt-to-equity ratio shows 0.42. Strict quality control and mandatory certification for every device make the brand's products indispensable for surgeons, who value instrument reliability in the operating room and avoid the risks associated with switching suppliers.

This indicator is calculated as the ratio of total credit obligations to net equity, measuring the business's reliance on borrowed funds and the sensitivity of the balance sheet structure to external debt. In the case of LeMaitre Vascular, Inc. (LMAT), exceptional margins and management discipline ensure a lack of leverage, rendering the ratio of total debt to equity an indicator of absolute financial autonomy.